- Tytuł:
-
An Open-Label Phase
I Study of Metformin and Nelfinavir in Combination With Bortezomib in Patients With Relapsed and Refractory Multiple Myeloma - Autorzy:
- Źródło:
- In Clinical Lymphoma, Myeloma and Leukemia January 2024
Czasopismo naukowe